1/23
Vocabulary practice flashcards covering the stages of hemostasis, platelet aggregation, and the intrinsic, extrinsic, and common pathways of the clotting cascade.
Hemostasis
The physiological process by which the body stops itself from bleeding following blood vessel damage.
Vascular Spasm
The first step of hemostasis, characterized by immediate vasoconstriction of a damaged blood vessel to narrow the lumen and mitigate blood loss.
Thromboxane A2
A prostaglandin released by damaged blood vessel cells that induces vasoconstriction and promotes platelet aggregation.
Platelet Plug
The second step of hemostasis in which circulating thrombocytes adhere to exposed basement membrane collagen and aggregate to form a mechanical barrier.
Von Willebrand Factor
A protein released by both endothelial cells and platelets that acts as an intermediate tether, binding negatively charged platelets to negatively charged collagen.
Von Willebrand Disease
A clinical condition resulting from a mutation that impairs von Willebrand factor expression, causing an affected individual to bleed much more easily.
Clotting Cascade
The third phase of hemostasis, involving a sequential series of liver-derived inactive protein factors numbered using Roman numerals that ultimately generates a stable meshwork.
Intrinsic Pathway
The clotting cascade pathway initiated internally by vascular damage, triggered directly by damaged endothelia, exposed collagen, and aggregated platelets.
Extrinsic Pathway
The clotting cascade pathway triggered from without by tissue damage that releases tissue factor into the circulation.
Thromboplastin
The specific tissue factor released by damaged tissue that initiates the extrinsic pathway of the clotting cascade.
Factor XII
The initial clotting factor in the intrinsic pathway, which is activated into factor 12a upon contacting damaged endothelia, exposed collagen, or aggregated platelets.
Factor XI
A clotting factor in the intrinsic pathway that is activated into factor 11a by activated factor 12a.
Factor IX
A clotting factor activated by factor 11a that complexes with factor VIII, calcium, and vitamin K to activate factor X.
Factor VIII
An intrinsic pathway clotting factor that complexes with activated factor 9a to enable the activation of factor X.
Factor VII
The primary circulating factor of the extrinsic pathway that becomes activated upon contact with thromboplastin and, alongside calcium and vitamin K, activates factor X.
Factor X
The common pathway convergence point where both the intrinsic and extrinsic cascades meet to initiate the final sequence of blood clotting.
Factor V
A clotting factor that forms a complex with activated factor 10a, calcium, and vitamin K to convert prothrombin into thrombin.
Prothrombin (Factor II)
An inactive plasma protein produced by the liver that is converted into active thrombin by activated factor 10a.
Thrombin
The active enzyme produced from prothrombin that enzymatically converts fibrinogen into insoluble fibrin monomers.
Fibrinogen (Factor I)
A soluble plasma protein synthesized in the liver that is cleaved by thrombin into fibrin.
Fibrin
Insoluble protein fiber strands that embed among aggregated platelets to create the structural meshwork of a clot.
Factor XIII
The clotting factor responsible for cross-linking fibrin fibers together to hold the clot strongly and securely in place.
Carboxylation by Vitamin K
The enzymatic modification that adds carboxyl groups (−COO−) to factors II, VII, IX, and X, making them negatively charged so that positive calcium ions can tether them to negative collagen and platelets.
Citrate
A negatively charged anticoagulant used to coat phlebotomy blood collection tubes to bind and remove calcium, thereby preventing in vitro clotting.